Biopharmaceutical considerations in subcutaneous and intramuscular drug administration.
D000042:Absorption; D000367:Age Factors; D000818:Animals; D002273:Carcinogens; D003692:Delayed-Action Preparations; D004339:Drug Compounding; D064420:Drug-Related Side Effects and Adverse Reactions; D004798:Enzymes / Q000494:pharmacology; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007273:Injections, Intramuscular; D007279:Injections, Subcutaneous; D007700:Kinetics; D009068:Movement; D010146:Pain; D010587:Phagocytosis; D004364:Pharmaceutical Preparations / Q000008:administration & dosage*; D012492:Salts; D012996:Solutions; D012997:Solvents; D013594:Syringes; D014783:Viscosity
D002273:Carcinogens; D003692:Delayed-Action Preparations; D004798:Enzymes; D004364:Pharmaceutical Preparations; D012492:Salts; D012996:Solutions; D012997:Solvents